Drug shortage
Candesartan Cilexetil Tablet · Par Pharmaceutical, Inc.
FDA drug shortage · To Be Discontinued · updated Oct 15, 2024
Key facts
| Generic name | Candesartan Cilexetil Tablet |
|---|---|
| Proprietary name | Atacand |
| Company | Par Pharmaceutical, Inc. |
| Presentation | Atacand, Tablet, 32 mg (NDC 49884-661-09) |
| Dosage form | Tablet |
| Strength | 32 mg |
| Status | To Be Discontinued |
| Therapeutic category | Cardiovascular |
| Package NDCs | 49884-661-09 |
| First posted | Oct 15, 2024 |
| Last updated | Oct 15, 2024 |
| Discontinued | Oct 15, 2024 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: